Literature DB >> 6850556

Chromosome 6 in malignant melanoma.

R Becher, Z Gibas, A A Sandberg.   

Abstract

Cytogenetic analysis of malignant melanoma (MM) cells from a number of cases revealed the frequent involvement of chromosome 6 in structural aberrations. The relevance of these findings to certain aspects of MM is briefly discussed.

Entities:  

Mesh：

Year:  1983        PMID： 6850556     DOI： 10.1016/0165-4608(83)90038-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


  5 in total

1.  Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines.

Authors:  A J Linnenbach; K Huebner; E P Reddy; M Herlyn; A H Parmiter; P C Nowell; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

Review 2.  Cytogenetic abnormalities in cancer: with special emphasis on tumor heterogeneity.

Authors:  S Pathak
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

3.  Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: verification by standard staining techniques, new densitometric methods, and somatic cell hybridization.

Authors:  J Squire; R A Phillips; S Boyce; R Godbout; B Rogers; B L Gallie
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 4.  The subpopulations and isolated cell types of freshly resected high grade human gliomas: their influence on the tumor's evolution in vivo and behavior and therapy in vitro.

Authors:  J R Shapiro; W R Shapiro
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 5.  Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells.

Authors:  G Parmiani; G Fossati; D Taramelli; A Anichini; A Balsari; C Gambacorti-Passerini; G Sciorelli; N Cascinelli
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.